Page 58 - Go4it

Chapter 4
Table 3: As continued
Fasting glucose, mmol/l I
C Glucose 120 min, mmol/l I C Fasting insulin, pmol/l I C Insulin 30 min, pmol/l I C Insulin 120 min, pmol/l I C HOMA-IR I C Systolic blood pressure, mmHg I Table 3: As continued C
Diastolic blood pressure, mmHg I Fasting glucose, mmol/l I
C C
HDL cholesterol, mmol/l I Glucose 120 min, mmol/l I
C C
Triglycerides, mmol/l I Fasting insulin, pmol/l I
C C
5.0 (0.3) 4.9 (0.3) 5.8 (1.1) 6.3 (1.1) 125 (59) 98 (58) 1297 (615) 1046 (625) 608 (380) 671 (486) 4.69 (2.36) 3.62 (2.19) 111 (13) 111 (10)
63 (8) 5.0 (0.3)
61 (7) 4.9 (0.3)
1.11 (0.25) 5.8 (1.1)
1.17 (0.24) 6.3 (1.1)
1.16 (0.66) 125 (59)
1.40 (0.55) 98 (58)
5.0 (0.4) 5.0 (0.5) 6.0 (1.1) 5.9 (1.1) 125 (68) 151 (77) 1266 (613) 1249 (887) 713 (464) 671 (359) 4.76 (2.90) 5.74 (3.19) 114 (13) 113 (14)
62 (7) 5.0 (0.4)
62 (9) 5.0 (0.5)
1.20 (0.24) 6.0 (1.1)
1.21 (0.24) 5.9 (1.1)
0.98 (0.60) 125 (68)
0.90 (0.30) 151 (77)
0.31 (-0.01; 0.62) -0.20 (-1.00; 0.61) - 1 (-37; 36) -130 (-648; 389) 26 (-252; 304) 0.24 (-1.23; 1.72) -9.3 (-17.7; -0.9)
Chapter 4
-6.6 (-12.9; -0.3)
0.31 (-0.01; 0.62)
0.16 (0.02; 0.30)
-0.20 (-1.00; 0.61)
Insulin 30 min, pmol/l I
The interaction of intervention*time was not significant for any of the outcome measurements, implying that the estima
1297 (615)
significantly by intervention. a I=Intervention group, C=control group, b Mean (sd, bold type indicates p<0.05, c B (95
C 1046 (625) and ethnicity; bold type indicates p<0.05
Insulin 120 min, pmol/l
HOMA-IR 58
Systolic blood pressure, mmHg Diastolic blood pressure, mmHg HDL cholesterol, mmol/l Triglycerides, mmol/l
I 608 (380) C 671 (486) I 4.69 (2.36) C 3.62 (2.19) I 111 (13)
C 111 (10)
I 63 (8)
C 61 (7)
I 1.11 (0.25) C 1.17 (0.24) I 1.16 (0.66) C 1.40 (0.55)
1266 (613) 1249 (887) 713 (464) 671 (359) 4.76 (2.90) 5.74 (3.19) 114 (13) 113 (14) 62 (7) 62 (9) 1.20 (0.24) 1.21 (0.24) 0.98 (0.60) 0.90 (0.30)
-130 (-648; 389) 26 (-252; 304) 0.24 (-1.23; 1.72) -9.3 (-17.7; -0.9) -6.6 (-12.9; -0.3) 0.16 (0.02; 0.30) -0.19 (-0.51; 0.13)
-0.19 (-0.51; 0.13) - 1 (-37; 36)
The interaction of intervention*time was not significant for any of the outcome measurements, implying that the estima significantly by intervention. a I=Intervention group, C=control group, b Mean (sd, bold type indicates p<0.05, c B (95 and ethnicity; bold type indicates p<0.05
58
t
t %
Chapter 4
Table 3: As continued
Fasting glucose, mmol/l I
5.0 (0.3) 4.9 (0.3) 5.8 (1.1) 6.3 (1.1) 125 (59) 98 (58) 1297 (615) 1046 (625) 608 (380) 671 (486) 4.69 (2.36) 3.62 (2.19) 111 (13) 111 (10)
5.0 (0.4) 5.0 (0.5) 6.0 (1.1) 5.9 (1.1) 125 (68) 151 (77) 1266 (613) 1249 (887) 713 (464) 671 (359) 4.76 (2.90) 5.74 (3.19) 114 (13) 113 (14)
0.31 (-0.01; 0.62) -0.20 (-1.00; 0.61) - 1 (-37; 36) -130 (-648; 389) 26 (-252; 304) 0.24 (-1.23; 1.72) -9.3 (-17.7; -0.9) -6.6 (-12.9; -0.3) 0.16 (0.02; 0.30) -0.19 (-0.51; 0.13)
0.03 (-0.20; 0.25) 0.26 (-0.43; 0.94) 10 (-25; 44) -349 (-895; 196) 37 (-264; 339) 0.22 (-1.25; 1.69) 0.4 (-6.3; 7.0) 5.4 (1.4; 9.6) 0.01 (-0.07; 0.09) -0.03 (-0.25; 0.19)
C Glucose 120 min, mmol/l I C Fasting insulin, pmol/l I C Insulin 30 min, pmol/l I C Insulin 120 min, pmol/l I C HOMA-IR I C Systolic blood pressure, mmHg I C Diastolic blood pressure, mmHg I C HDL cholesterol, mmol/l I C Triglycerides, mmol/l I C
63 (8)
62 (7)
61 (7) 1.11 (0.25) 1.17 (0.24) 1.16 (0.66) 1.40 (0.55)
62 (9) 1.20 (0.24) 1.21 (0.24) 0.98 (0.60) 0.90 (0.30)
The interaction of intervention*time was not significant for any of the outcome measurements, implying that the estimated time effect did not differ significantly by intervention. a I=Intervention group, C=control group, b Mean (sd, bold type indicates p<0.05, c B (95% CI) adjusted for age, sex and ethnicity; bold type indicates p<0.05
58